当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease

"酶免"产品文献：Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease

酶免官方商城 / 2023-08-25

文献标题

Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease

文献作者

Hu Y、Tang W、Liu W、Hu Z、Pan C

发表时间

2022年05月31日

文献影响因子

4.278

使用的酶免科研试剂盒产品名称

小鼠神经趋化蛋白（CX3CL1）ELISA科研试剂盒

下一篇:"酶免"产品文献：Transcriptome analysis of healthy and fatty liver revealed that inhibition of SLCO1B3 induces abnormal liver metabolism and lipid synthesis
上一篇:"酶免"产品文献：Dietary supplementation of bilberry anthocyanin on growth performance, intestinal mucosal barrier and cecal microbes of chickens challenged with Salmonella typhimurium

全部产品分类

浏览历史

"酶免"产品文献：Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease